Overview
I am a hematology/oncology fellow and post-doctoral fellow in the National Clinician Scholars Program at Duke University School of Medicine. I envision a career as an oncologist, health services/outcomes, and equity researcher focused on addressing disparities in care for patients with hematologic malignancies from under-represented backgrounds. I am interested in understanding how epidemiology, patterns, quality, and cost of care impact healthcare delivery and outcomes in patients with hematologic malignancies from under-represented backgrounds, with particular attention to factors along the continuum of care, to ultimately guide the development of appropriate interventions to address inequities.
Current Duke Appointments & Affiliations
Student
Medicine,
Clinical Science Departments
Student
Medicine, Medical Oncology,
Medicine
Recent Scholarly Works
Real-World Outcomes in First-Line Venetoclax-Based Therapy in Patients With AML Ineligible for Intensive Chemotherapy: A Single Center Study.
Journal article Clin Lymphoma Myeloma Leuk · October 2026 BACKGROUND: VIALE-A established azacitidine and venetoclax as first-line therapy for patients with acute myeloid leukemia (AML) ineligible for intensive chemotherapy. However, real-world use of venetoclax often differs from clinical trial protocols. PATIEN ... Full text Link to item CiteClinical, Ethical, and Financial Considerations With Red Blood Cell Transfusion Support at the End of Life in Hematologic Malignancies.
Journal article Am J Hosp Palliat Care · June 22, 2026 Patients with advanced hematological malignancies often have red blood cell (RBC) transfusion needs at the end of life (EOL) to improve debilitating anemia-related symptoms. Given that patients with hematologic malignancies and their caregivers find that t ... Full text Link to item CiteSociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms.
Journal article Bone Marrow Transplant · June 2026 Full text Link to item CiteRecent Grants
Experience of Veterans with Myeloproliferative Neoplasms
ResearchPrincipal Investigator · Awarded by American Society of Clinical Oncology · 2025 - 2026Exploring the impact of conditioning regimen selection on clinical outcomes and quality of life in
ResearchPI-Fellow · Awarded by American Society of Hematology · 2024 - 2026View All Grants